Target intelligence / Profile preview

Pre-mRNA processing factor 40 homolog B (PRPF40B)

Target
PRPF40B
Molecular classification
Splicing factor, RNA-binding protein (by association, not via classical RNA recognition motif), U1 small nuclear ribonucleoprotein (snRNP)-associated protein, Other (core component of spliceosomal machinery)
01

Overview

Pre-mRNA processing factor 40 homolog B (PRPF40B) is a human protein that acts as a splicing factor, associating with the U1 small nuclear ribonucleoprotein (snRNP) complex and interacting directly with SF1 and U2AF(65) proteins to facilitate the accurate assembly of spliceosomal machineries at pre-mRNA splice sites[1][2]. PRPF40B helps modulate alternative splicing, especially repressing exon inclusion for weak splice sites and regulating genes critical for cell survival and apoptosis, such as Fas[1][2]. Loss of PRPF40B disrupts normal alternative splicing patterns, induces apoptosis, and alters expression of genes involved in iron metabolism, hypoxia, and cholesterol biosynthesis—implicated in certain cancers, including acute myeloid leukemia and myelodysplastic syndrome[2][3]. PRPF40B does not contain an RNA recognition motif but functions through interactions mediated by WW and FF domains[2]. There are currently no drugs or therapeutic biologics developed to target PRPF40B directly.

Other names
PRP40 pre-mRNA processing factor 40 homolog BHuntingtin-interacting protein CHuntingtin yeast partner CHYPCPre-mRNA-processing factor 40 homolog BPRPF40B
02

Biological functions

Alternative pre-mRNA splicing regulationCotranscriptional modulation of splicing site selectionInteraction with SF1 and U2AF(65) to join 5′ and 3′ splice site complexesRegulates genes involved in apoptosis (e.g., Fas)Influences transcriptional programs related to iron metabolism, hypoxia, and cholesterol biosynthesis
03

Disease associations

Cancer (especially acute myeloid leukemia and myelodysplastic syndromes due to altered splicing)Neurodegenerative disease (interacts with huntingtin in Huntington’s disease brains, unclear significance)Other hematological disorders (via alternative splicing defects)

Beyond the preview

Go deeper on Pre-mRNA processing factor 40 homolog B (PRPF40B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-mRNA processing factor 40 homolog B (PRPF40B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call